Leveraging AI in clinical development

Parexel’s AI solutions accelerate first-time quality and milestone delivery through our strategic operating model, Parexel Precision Pathway. We’re committed to the development of innovative, high-value use cases for AI in clinical trials. AI empowers our people at critical decision points and our AI investments prioritize process optimizations that:

1. Simplify complex tasks to accelerate timelines
2. Apply insights with agility to enable better decision-making
3. Enhance data handling to drive first-time quality

Parexel has implemented AI and other advanced technologies to accelerate clinical trial execution, while always maintaining the human in the loop. Use cases include:

Study design and planning

• Study design optimization

• Precise site selection 

• Patient identification 

Study start-up and execution

• Achieve increased speed and quality of statistical programming
• Site contracting, grant management and payment solutions
• Monitoring visit preparation and report generation 

Clinical trial data and analysis

• SDTM conversion and automated data workflows

Regulatory and safety

• Accelerate speed of delivery in medical writing
• Improve efficiency and effectiveness of regulatory affairs functions
• Streamline adverse event case processing for speed and higher quality

Post Approval

• Enhance evidence generation for market access and HEOR strategy 

Operational productivity

• Nearly 50 robotic process automation (RPA – aka bots) solutions have been deployed in workflows across Parexel. These bots drive efficiency, enable faster timelines, and deliver first time quality

Meaningful change always starts with a vision.

We envisioned an AI-enabled platform that automates data management processes end to end—from data input, through analysis, to regulatory submission. Today we’re building the end-to-end AI ecosystem with Palantir Technologies Inc, a software company that builds platforms to power real-time, AI-driven decision-making.

Palantir’s core product, AIP, is used to create a central operating system with tools that support AI automation combined with human-in-the-loop decision making. Parexel is using AIP as the engine to transform trial execution from silos of semi-manual tasks to highly efficient AI-powered workflows.

“Data standardization is the foundation for unlocking the value of AI in clinical research. We believe the combination of Palantir’s AIP platform and Parexel’s vision for clinical trial transformation will set new benchmarks for speed, accuracy and first-time quality.”

-Dan Ballard, Senior Vice President, Digital Enablement and Innovation

Ethically leveraging AI in clinical trials 

The six principles set out below describe how Parexel conceives, develops, deploys, and monitors AI applications intended for use in clinical development and throughout our business. By adhering to these tenets, we ensure that Parexel respects the rights of all relevant stakeholders, mitigates or eliminates known risks, and uses AI applications safely.

1. Thoughtful design and deployment
2. Accountability and senior-level governance
3. Human oversight and control
4. Transparent AI
5. Regulatory conformance and legal compliance
6. Security and privacy

Learn more about Parexel’s principles for artificial intelligence and how we are applying them to build an AI roadmap with solutions that are conceived, developed, and deployed responsibly.
 

Download PDF

Our journey with AI and HyperAutomation is just beginning. We look forward to sharing how we’re using AI to help manage the increasing complexity of clinical development, including opportunities to expedite development timelines so life-changing  products reach patients quicker. 
 

Let's start a conversation